MARATTO

article · Annals of Medicine and Surgery

Acute limb ischemia in a child revealing acute myeloid leukemia: a case report and literature review

2025Open accessMohamed I University

Abstract

Introduction and importance: Acute limb ischemia in children is rare and typically occurs secondary to trauma or iatrogenic injury. Arterial thrombosis as the initial manifestation of acute myeloid leukemia (AML) is exceptional. Early diagnosis is essential to prevent irreversible complications. Case presentation: We report the case of an 11-year-old boy with no prior medical history, admitted with acute right lower limb ischemia. Imaging revealed occlusion of the superficial femoral artery. Surgical management included double thromboembolectomy and femoropopliteal bypass. Laboratory investigations showed pancytopenia, and bone marrow biopsy confirmed AML. Despite prompt initiation of chemotherapy, the ischemia progressed, leading to above-knee amputation. Clinical discussion: Large-vessel arterial thrombosis as a presenting feature of AML in children is extremely rare. The hypercoagulable state associated with leukemia can lead to such vascular events. This case underlines the importance of considering hematologic malignancy in pediatric patients with unexplained acute limb ischemia. Conclusion: Acute limb ischemia can be the first sign of AML in children. Early multidisciplinary management is critical for improving survival and optimizing outcomes, although limb salvage is not always achievable.

Research topics

  • Blood Coagulation and Thrombosis Mechanisms
  • Venous Thromboembolism Diagnosis and Management
  • Peripheral Artery Disease Management

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1097/ms9.0000000000003874

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.